NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 110 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $225,902 | -24.6% | 211,123 | +82.6% | 0.00% | – |
Q2 2023 | $299,414 | +10968.9% | 115,604 | -82.6% | 0.00% | -100.0% |
Q1 2023 | $2,705 | +17.6% | 662,966 | +44.7% | 0.00% | +100.0% |
Q4 2022 | $2,300 | -99.9% | 458,230 | +98.5% | 0.00% | -50.0% |
Q3 2022 | $3,019,000 | -46.7% | 230,846 | -47.7% | 0.00% | -50.0% |
Q2 2022 | $5,660,000 | -11.1% | 441,475 | +5.8% | 0.00% | +33.3% |
Q1 2022 | $6,366,000 | -32.7% | 417,416 | -21.9% | 0.00% | -40.0% |
Q4 2021 | $9,463,000 | +53.4% | 534,349 | +82.1% | 0.01% | +66.7% |
Q3 2021 | $6,168,000 | +654.0% | 293,442 | +607.1% | 0.00% | – |
Q2 2021 | $818,000 | +87.6% | 41,501 | +176.7% | 0.00% | – |
Q1 2021 | $436,000 | -69.5% | 15,000 | -83.3% | 0.00% | -100.0% |
Q3 2020 | $1,429,000 | +518.6% | 89,803 | +667.4% | 0.00% | – |
Q2 2020 | $231,000 | -80.3% | 11,703 | -87.7% | 0.00% | -100.0% |
Q1 2020 | $1,172,000 | -7.4% | 95,082 | +38.9% | 0.00% | +50.0% |
Q4 2019 | $1,265,000 | +538.9% | 68,435 | +377.7% | 0.00% | – |
Q3 2019 | $198,000 | -72.4% | 14,327 | -70.8% | 0.00% | -100.0% |
Q2 2019 | $718,000 | – | 49,016 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 3,766,666 | $59,928,000 | 49.90% |
Greenspring Associates, LLC | 1,573,357 | $25,032,000 | 38.95% |
Svennilson Peter | 18,017,932 | $286,665,000 | 23.39% |
Aquilo Capital Management, LLC | 1,018,334 | $16,202,000 | 1.72% |
Jasper Ridge Partners, L.P. | 308,750 | $4,912,000 | 0.28% |
Samsara BioCapital, LLC | 36,451 | $580,000 | 0.16% |
Rock Springs Capital Management LP | 360,454 | $5,735,000 | 0.15% |
Point72 Asset Management, L.P. | 1,611,850 | $25,645,000 | 0.13% |
Virtus ETF Advisers LLC | 14,880 | $237,000 | 0.12% |
WELD CAPITAL MANAGEMENT LLC | 15,238 | $242,000 | 0.10% |